824 related articles for article (PubMed ID: 22432744)
1. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
2. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
Ajamieh H; Farrell GC; McCuskey RS; Yu J; Chu E; Wong HJ; Lam W; Teoh NC
Liver Int; 2015 Sep; 35(9):2174-86. PubMed ID: 25786512
[TBL] [Abstract][Full Text] [Related]
3. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury.
Teoh NC; Williams J; Hartley J; Yu J; McCuskey RS; Farrell GC
Hepatology; 2010 Mar; 51(3):996-1006. PubMed ID: 20131406
[TBL] [Abstract][Full Text] [Related]
4. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
5. Enhancing organ pool by statins: is this the future?
Gracia-Sancho J
J Gastroenterol Hepatol; 2012 Aug; 27(8):1259-60. PubMed ID: 22823912
[No Abstract] [Full Text] [Related]
6. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
[TBL] [Abstract][Full Text] [Related]
7. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
[TBL] [Abstract][Full Text] [Related]
8. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
9. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
[TBL] [Abstract][Full Text] [Related]
12. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
Ni R; Peleg T; Gross PL
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
[TBL] [Abstract][Full Text] [Related]
15. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.
Kim K; Jung N; Lee K; Choi J; Kim S; Jun J; Kim E; Kim D
Clin Nutr; 2013 Oct; 32(5):855-62. PubMed ID: 23395256
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
17. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice.
Kuboki S; Schuster R; Blanchard J; Pritts TA; Wong HR; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1141-9. PubMed ID: 17185630
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
19. Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.
Shen KP; Lin HL; Chang WT; An LM; Chen IJ; Wu BN
J Pharm Pharmacol; 2011 Jun; 63(6):860-8. PubMed ID: 21585385
[TBL] [Abstract][Full Text] [Related]
20. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
